Avista Healthcare

New York, NY, February 13, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $210 million. BioReliance is a leading contract service organization providing biological safety testing, toxicology, viral manufacturing, and laboratory […]

New York, NY, October 10, 2006 – Avista Capital Partners, a leading private equity firm, today announced it has committed to purchase up to €125 million of common stock in Nycomed A/S (“Nycomed”). Based in Roskilde, Denmark, Nycomed is a mid-size pharmaceutical company focused on the sale of branded prescription and over-the-counter drugs in the […]

Houston, TX, October 3, 2006 – PRNewswire — Avista Capital Partners, a leading private equity firm, today announced it has committed to purchase up to $50 million in MedServe, Inc. to fund a national consolidation of small operators in the medical waste industry. Based in Houston, Texas, MedServe provides medical waste removal and destruction and […]

HAMILTON, Bermuda, September 21, 2006 – PRNewswire-FirstCall — Warner Chilcott Limited today announced the pricing of its initial public offering of 70,600,000 shares of common stock, at a price of $15 per share. The shares will be listed on the Nasdaq Global Select Market and will trade under the symbol “WCRX” beginning September 21, 2006. […]

Lyndhurst, NJ, and Herndon, VA, May 19, 2006 – PRNewswire-FirstCall — Quest Diagnostics Incorporated , the nation’s leading provider of diagnostic testing, information and services, has agreed to acquire Focus Diagnostics, Inc., the premier infectious disease testing provider, in a cash transaction valued at approximately $185 million. Focus Diagnostics is privately held and based in […]